The counterterrorism and targeted violence prevention fields are beginning to recognize that artificial intelligence is ...

The FDA has approved Otarmeni, the first-ever gene therapy for genetic hearing loss caused by the OTOF gene, for both ...

Ford engineers are studying whether AI can play a role in detecting faulty run-downs. To do that, they first had to determine ...

Two papers published in The New England Journal of Medicine highlight the potential of gene editing for treatment of sickle ...

A10 continued to deliver growth and profitability in the second quarter. This performance demonstrates the continued ...

The NIC market sees growth fueled by demand for high-speed, secure networks driven by cloud, IoT, and SmartNIC innovations. Opportunities arise in edge computing, 5G expansion, and AI applications, ...

As the Israeli military continues its military aggression across the region, new revelations have emerged detailing the ...

Welcome to another installment of This Week at FDA, your weekly source for updates – big and small – on FDA, drug and medical ...

Neuronal specification, expansion and differentiation are tightly regulated by the concerted actions of transcription and chromatin modifying factors that are recruited to regulatory elements in the ...

This week’s Web3 Thoughts of the Week tackles DoorDash and stablecoins, spot Bitcoin ETFs, and DeFi’s tattered image.

ServiceNow’s earnings call painted a picture of a company executing well on growth, profitability and AI innovation, even as markets fret over deal timing and M&A optics. For investors, the core ...

As the Russian-Ukrainian conflict drags on without any breakthrough, diplomatic endeavors have begun shifting from grand ...